Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen, Carboplatin and Topotecan for Recurrent Brain Tumors
NCT00541138Phase 2Completed
- Sponsor
- City of Hope
- Start
- May 2003
- Primary completion
- Oct 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tamoxifen, carboplatin and topotecan in glioma and brain metastases, sponsored by City of Hope. Primary endpoints: Toxicity profile, Response rate and 3 more. Started May 2003; status: completed.
02
Drugs
tamoxifencarboplatintopotecan
03
Conditions
gliomabrain metastases
Beyond the preview
Go deeper on NCT00541138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541138.